T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity

Anne R. Gocke, Petra D. Cravens, Li Hong Ben, Rehana Z. Hussain, Sara C. Northrop, Michael K. Racke, Amy E. Lovett-Racke

Research output: Contribution to journalArticlepeer-review

205 Scopus citations


IL-17-preducing T cells (Th17) have recently been implicated in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), am animal model for the human disease multiple sclerosis. However, little is known about the transcription factors that regulate these cells. Although it is clear that the transcription factor T-bet plays an essential role in the differentiation of IFN-γ-producing CD4+ Th1 lymphocytes, the potential role of T-bet in the differentiation of Th17 cells is not completely understood. In this study, therapeutic administration of a small interfering RNA specific for T-bet significantly improved the clinical coarse of established EAE. The improved clinical course was associated with suppression of newly differentiated T cells that express IL-17 in the CNS as well as suppression of myelin basic protein-specific Th1 autoreactive T cells. Moreover, T-bet was found to directly regulate transcription of the IL-23R, and, in doing so, influenced the fate of Th17 cells, which depend on optimal IL-23 production for survival. We now show for the first time that suppression of T-bet ameliorates EAE by limiting the differentiation of autoreactive Th1 cells, as well as pathogenic pathogenic Th17 cells via regulation of IL-23R.

Original languageEnglish (US)
Pages (from-to)1341-1348
Number of pages8
JournalJournal of Immunology
Issue number3
StatePublished - Feb 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity'. Together they form a unique fingerprint.

Cite this